Come stanno i Milanesi - ASL Milano

Elenco delle sezioni principali del sito:

You are: Cancer » Thyroid » Ladies

Thyroid - Ladies

Rates per 100,000 inhabitants

Table 1: Incidence: frequencies, crude and standardized rates per year

Incidence		1999	2000	2001	2002	2003	2004	2005	2006	1999‑2006
Count		84	92	87	95	102	98	89	79	726
Crude rate		12.4	13.6	12.9	14.2	15.3	14.5	13.0	11.4	13.4 (12.5‑14.4)
Standardized rate	Italy 2001	11.1	13.0	11.9	13.2	14.5	13.1	11.5	10.7	12.4 (11.5‑13.4)
Standardized rate	Europe	9.6	12.1	10.8	11.9	13.3	11.5	9.9	9.9	11.1 (10.3‑12.0)
Standardized rate	World	7.7	10.2	9.0	10.2	11.2	9.1	7.7	8.2	9.2 (8.4‑10.0)

Table 2: Mortality: frequencies, crude and standardized rates per year

Mortality		1999	2000	2001	2002	2003	2004	2005	2006	1999‑2006
Count		12	10	10	5	11	14	9	13	84
Crude rate		1.8	1.5	1.5	0.7	1.7	2.1	1.3	1.9	1.6 (1.2‑1.9)
Standardized rate	Italy 2001	1.3	1.0	1.1	0.5	1.1	1.5	0.9	1.4	1.1 (0.9‑1.4)
Standardized rate	Europe	0.7	0.6	0.8	0.3	0.7	1.0	0.5	1.0	0.7 (0.5‑0.9)
Standardized rate	World	0.5	0.4	0.5	0.2	0.4	0.7	0.4	0.7	0.5 (0.3‑0.6)

Table 3: Register quality indicators per year

Indicator	1999	2000	2001	2002	2003	2004	2005	2006	1999‑2006
Mortality/Incidence ratio (%)	11.7	7.7	9.2	3.8	7.6	11.5	7.8	13.1	8.9
Cito-histologically confirmed (%)	86.9	95.7	94.3	94.7	100.0	96.9	97.8	97.5	95.6
Death certificate only - DCO (%)	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3

Table 4: Comparison of Italian Registries mean prevalence by macro-areas

Graf 04

_	Milan	North West	North East	Centre	South	Italy
Incidence	11.2	13.6	20.4	15.0	16.6	17.9
Mortality	0.8	0.7	0.6	0.6	0.6	0.6

Table 5: Basis of diagnosis per period

_	1999‑2002	%	2003‑2006	%	1999‑2006	%
Histological	325	90.8	354	96.2	679	93.5
Citological	8	2.2	7	1.9	15	2.1
Clinical	24	6.7	6	1.6	30	4.1
DCO	1	0.3	1	0.3	2	0.3

Table 6: More frequent morphologies

Morphology	N	%
Papillary carcinoma, NOS	149	41.3
Papillary carcinoma, follicular variant (C73.9)	70	19.4
Papillary adenocarcinoma, NOS	51	14.1
Papillary microcarcinoma (C73.9)	15	4.2
Follicular adenocarcinoma, NOS (C73.9)	15	4.2
Follicular carcinoma, minimally invasive (C73.9)	12	3.3

Table 7: Age distribution of rates

Graf 07

Age groups	Incidence	Mortality
0	0.0	0.0
1-4	0.0	0.0
5-9	0.0	0.0
10-14	0.0	0.0
15-19	4.8	0.0
20-24	3.0	0.0
25-29	9.0	0.0
30-34	12.0	0.0
35-39	12.2	0.0
40-44	21.0	0.0
45-49	16.9	0.6
50-54	22.2	0.6
55-59	23.4	0.5
60-64	22.5	2.1
65-69	11.5	5.2
70-74	21.6	3.4
75-79	14.6	6.6
80-84	10.4	7.8
85+	5.0	5.0

Table 8: Temporal trends of rates

Graf 08

Year	Mortality	Incidence
1999	0.7	9.6
2000	0.6	12.1
2001	0.8	10.8
2002	0.3	11.9
2003	0.7	13.3
2004	1.0	11.5
2005	0.5	9.9
2006	1.0	9.9

Table 10: Comparison of Italian Registries mean prevalence by macro-areas

Graf 10

Years since diagnosis	Italy	South	Centre	North East	North West	Milan
0-2	37.2	38.0	39.2	43.6	25.3	25.3
2-5	48.5	50.8	48.6	52.9	39.4	37.3
5-10	53.0	54.0	56.9	52.7	47.9	46.3
10-15	32.1	31.3	26.0	38.3	29.0	27.2
15-20	20.0	16.9	19.6	21.3	20.2	16.5
>20	24.8	18.9	24.7	28.0	23.8	21.5

Table 11: 5 years relative survival by macro-areas

Graf 11

Area	Relative survival (95% CI)
Milan	88.9 (85.7‑92.1)
North West	91.5 (89.6‑93.1)
North Est	92.8 (91.4‑93.9)
Centre	89.1 (86.5‑91.3)
South	88.6 (85.8‑90.9)
Italy	91.4 (90.5‑92.2)

Table 12: Relative survival by age since diagnosis

Age class	0	1	2	3	4	5
15-44	100.00	100.00	99.60	99.60	99.60	99.60
45-59	100.00	100.00	99.50	97.90	97.70	96.40
60-74	100.00	93.30	92.20	92.20	92.20	92.20
75+	100.00	60.60	55.60	55.60	52.40	52.40

Table 13: 5 years relative survival by biennium of incidence

Years since diagnosis	1999‑2000	2001‑2002	2003‑2004	2005‑2006
1	94.3	94.8	92	95.8
2	93.6	93	90.9	94.5
3	93.6	92.9	90.6	92.7
4	92.9	92.5	90.6	92.6
5	92.3	92	89.7	92.6

Table 14: Rates distribution by deprivation index

‑	1	2	3	4	5
Incidence	13.7	13.3	11.4	13.5	13.6
Mortality	1.7	2	1.7	2.3	0.8

Table 15: Relative survival by deprivation index

Years since diagnosis	Most deprived	Most affluent
0	100.0	100.0
1	93.9	96.6
2	92.1	96.6
3	90.2	95.8
4	88.4	95.8
5	86.3	94.3